Literature DB >> 17077872

Surgical management of petroclival chordomas: report of eight cases.

Toshihiro Takami1, Kenji Ohata, Takeo Goto, Naohiro Tsuyuguchi, Akimasa Nishio, Mitsuhiro Hara.   

Abstract

In the management of skull base chordomas, surgical treatment is essential to achieve long-term control. A petroclival chordoma growing laterally in the skull base is one of the most challenging tumors for neurosurgeons. We have treated petroclival chordomas based on the principle of maximal surgical resection of the tumor with minimal morbidity. Lateral skull base approaches were used to approach petroclival chordomas in eight patients. The surgical procedure involved removal of soft tumor tissue and extensive drilling of adjacent bony structures. Gross total resection of the tumor was achieved in six patients. Subtotal resection in the remaining two patients was associated with acceptable morbidity. In cases of petroclival chordomas, lateral skull base approaches can be used as a primary procedure, although those approaches may be associated with high rates of morbidity and mortality.

Entities:  

Year:  2006        PMID: 17077872      PMCID: PMC1502032          DOI: 10.1055/s-2006-934109

Source DB:  PubMed          Journal:  Skull Base        ISSN: 1531-5010


  23 in total

1.  Petrosal approach for petroclival meningiomas.

Authors:  O Al-Mefty; J L Fox; R R Smith
Journal:  Neurosurgery       Date:  1988-03       Impact factor: 4.654

2.  Transtemporal approach to the skull base: an anatomical study.

Authors:  L N Sekhar; R Estonillo
Journal:  Neurosurgery       Date:  1986-11       Impact factor: 4.654

3.  Indications and techniques of midfacial degloving. A 15-year experience.

Authors:  A J Maniglia
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1986-07

4.  Experiences with a translabyrinthine-transtentorial approach to the cerebellopontine angle. Technical note.

Authors:  A W Morrison; T T King
Journal:  J Neurosurg       Date:  1973-03       Impact factor: 5.115

5.  A combined approach to the cerebellopontine angle. A suboccipital-petrosal approach.

Authors:  W E Hitselberger; W F House
Journal:  Arch Otolaryngol       Date:  1966-09

6.  A modified extended middle cranial fossa approach for acoustic nerve tumors. Results of 125 operations.

Authors:  R Shiobara; T Ohira; J Kanzaki; S Toya
Journal:  J Neurosurg       Date:  1988-03       Impact factor: 5.115

7.  Extended osteoplastic maxillotomy. A versatile new procedure for wide access to the central skull base and infratemporal fossa.

Authors:  P J Catalano; H F Biller
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1993-04

8.  Infratemporal fossa approach to lesions in the temporal bone and base of the skull.

Authors:  U Fisch; H C Pillsbury
Journal:  Arch Otolaryngol       Date:  1979-02

9.  Intracranial chordomas: a clinicopathological and prognostic study of 51 cases.

Authors:  P A Forsyth; T L Cascino; E G Shaw; B W Scheithauer; J R O'Fallon; J C Dozier; D G Piepgras
Journal:  J Neurosurg       Date:  1993-05       Impact factor: 5.115

10.  Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients.

Authors:  E Gay; L N Sekhar; E Rubinstein; D C Wright; C Sen; I P Janecka; C H Snyderman
Journal:  Neurosurgery       Date:  1995-05       Impact factor: 4.654

View more
  3 in total

1.  Systematic Review Comparing Open versus Endoscopic Surgery in Clival Chordomas and a 10-Year Single-Center Experience.

Authors:  Asfand Baig Mirza; Visagan Ravindran; Mohamed Okasha; Timothy Martyn Boardman; Eleni Maratos; Barazi Sinan; Nick Thomas
Journal:  J Neurol Surg B Skull Base       Date:  2021-02-22

Review 2.  Adjuvant radiation therapy and chondroid chordoma subtype are associated with a lower tumor recurrence rate of cranial chordoma.

Authors:  Brian J Jian; Orin G Bloch; Isaac Yang; Seunggu J Han; Derick Aranda; Tarik Tihan; Andrew T Parsa
Journal:  J Neurooncol       Date:  2009-12-02       Impact factor: 4.130

3.  Computed tomography-guided argon-helium cryoablation for sacrum chordoma.

Authors:  Liang Li; Xiao-Fan Jiang; Li-Jun Sun; Yu-Fei Fu; Wei Zhang
Journal:  Medicine (Baltimore)       Date:  2020-10-16       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.